FR2943545B1 - Nanoparticules lipidiques solides encapsulant du minoxidil et suspension aqueuse les contenant. - Google Patents

Nanoparticules lipidiques solides encapsulant du minoxidil et suspension aqueuse les contenant.

Info

Publication number
FR2943545B1
FR2943545B1 FR0952059A FR0952059A FR2943545B1 FR 2943545 B1 FR2943545 B1 FR 2943545B1 FR 0952059 A FR0952059 A FR 0952059A FR 0952059 A FR0952059 A FR 0952059A FR 2943545 B1 FR2943545 B1 FR 2943545B1
Authority
FR
France
Prior art keywords
minoxidil
aqueous suspension
suspension containing
lipid nanoparticles
containing same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0952059A
Other languages
English (en)
Other versions
FR2943545A1 (fr
Inventor
Karine Padois
Fabrice Pirot
Francoise Falson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite Claude Bernard Lyon 1 UCBL
Original Assignee
Universite Claude Bernard Lyon 1 UCBL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite Claude Bernard Lyon 1 UCBL filed Critical Universite Claude Bernard Lyon 1 UCBL
Priority to FR0952059A priority Critical patent/FR2943545B1/fr
Priority to PCT/FR2010/050574 priority patent/WO2010112749A1/fr
Priority to EP10715993A priority patent/EP2413918A1/fr
Publication of FR2943545A1 publication Critical patent/FR2943545A1/fr
Application granted granted Critical
Publication of FR2943545B1 publication Critical patent/FR2943545B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR0952059A 2009-03-31 2009-03-31 Nanoparticules lipidiques solides encapsulant du minoxidil et suspension aqueuse les contenant. Expired - Fee Related FR2943545B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR0952059A FR2943545B1 (fr) 2009-03-31 2009-03-31 Nanoparticules lipidiques solides encapsulant du minoxidil et suspension aqueuse les contenant.
PCT/FR2010/050574 WO2010112749A1 (fr) 2009-03-31 2010-03-29 Nanoparticules lipidiques solides encapsulant du minoxidil et suspension aqueuse les contenant
EP10715993A EP2413918A1 (fr) 2009-03-31 2010-03-29 Nanoparticules lipidiques solides encapsulant du minoxidil et suspension aqueuse les contenant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0952059A FR2943545B1 (fr) 2009-03-31 2009-03-31 Nanoparticules lipidiques solides encapsulant du minoxidil et suspension aqueuse les contenant.

Publications (2)

Publication Number Publication Date
FR2943545A1 FR2943545A1 (fr) 2010-10-01
FR2943545B1 true FR2943545B1 (fr) 2011-06-03

Family

ID=41258609

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0952059A Expired - Fee Related FR2943545B1 (fr) 2009-03-31 2009-03-31 Nanoparticules lipidiques solides encapsulant du minoxidil et suspension aqueuse les contenant.

Country Status (3)

Country Link
EP (1) EP2413918A1 (fr)
FR (1) FR2943545B1 (fr)
WO (1) WO2010112749A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ307681B6 (cs) 2016-02-29 2019-02-13 Ústav makromolekulární chemie AV ČR, v. v. i. Fotoaktivovatelná nanočástice pro fotodynamické aplikace, způsob její přípravy, farmaceutická kompozice ji obsahující a jejich použití
WO2023275648A1 (fr) 2021-06-30 2023-01-05 Novocure Gmbh Compositions et procédés d'utilisation de champs électriques alternatifs pour perturber des capsules lipidiques
CN113797208B (zh) * 2021-11-17 2022-02-25 山东谷雨春生物科技有限公司 一种含米诺地尔的制剂及其制备方法和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1298575B1 (it) * 1998-02-06 2000-01-12 Vectorpharma Int Composizioni farmaceutiche in forma di nanoparticelle comprendenti sostanze lipidiche e sostanze antifiliche e relativo processo di

Also Published As

Publication number Publication date
WO2010112749A1 (fr) 2010-10-07
EP2413918A1 (fr) 2012-02-08
FR2943545A1 (fr) 2010-10-01

Similar Documents

Publication Publication Date Title
CL2015000501A1 (es) Nanopartícula polimérica de finasterida y minoxidil, proceso de preparación, suspensión acuosa conteniendo la misma, composición farmacéutica, y su uso.
BRPI1014027A2 (pt) suspensão de fármaco de nanopartícula estável.
BRPI0915566A2 (pt) suplemento probiótico, rpocesso de fabricação e embalagem
CL2014003370A1 (es) Composición acuosa estable de anticuerpos anti-baffr; y dispositivo de suministro de la composición.
BRPI0906611A2 (pt) Produtos implantáveis compreendendo nanopartículas.
EP2252664A4 (fr) Particules à l'échelle nanométrique encapsulées de pigments organiques
MX323219B (es) Perfumes y encapsulados de perfume.
FR2960749B1 (fr) Contenant cosmetique
PL2594140T3 (pl) Nanocząstki do kapsułkowania związków, ich wytwarzanie i zastosowanie
FR2989001B1 (fr) Microparticules et nanoparticules constituees de polysaccharides hydrophobises et d'une alpha-cyclodextrine
BRPI0822221A2 (pt) Composições aquosas e estáveis de ciclosporina
BR112013016212A2 (pt) composição aquosa de cuidado oral compreendendo goma xantana, goma de celulose e carbômero.
CL2013000201A1 (es) Composiciones farmaceuticas combinadas que comprenden una forma activada potenciada de anticuerpos contra la proteina s-100 de cerebro y una forma activada potenciada de anticuerpos contra nos endotelial; metodo de tratamiento del vertigo la cinetosis y la distonia vegetativa-vascular.
FR2914854B1 (fr) Solution aqueuse de conservateur a haute teneur en aminoacides et cosmetique la contenant.
FR2945921B1 (fr) Recipient cosmetique
EP2812377A4 (fr) Suspension aqueuse de poudre composite de silicone, émulsion e/h et cosmétiques
FR2937549B1 (fr) Nanoparticules de derives beta-lactamine
PL395002A1 (pl) Hybrydowy material zawierajacy nanoczastki srebra, sposób wytwarzania materialu hybrydowego oraz jego zastosowanie
FR2955038B1 (fr) Nanoparticules anti-uv
FR2995770B1 (fr) Contenant cosmetique
FR2943545B1 (fr) Nanoparticules lipidiques solides encapsulant du minoxidil et suspension aqueuse les contenant.
FR2966834B1 (fr) Dispersion aqueuse pigmentaire et ses utilisations cosmetiques
BRPI1007812A2 (pt) lipoatrofia cosmética medicinal
DK2964199T3 (da) Tørre farmaceutiske sammensætninger omfattende aktivstof-nanopartikler bundet til bærerpartikler
ZA201304246B (en) Gelatin encapsulated oral care composition containing hydrophilic active,hydrophobic structuring agent and oil carrier

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20151130